Drugs / Qingre Huoxue granule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02551575 | Nov 2014 → Jun 2017 | rheumatoid arthritis | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qingre Huoxue granule | “Qingre Huoxue granule: 10g, 2 times a day, oral, for 24 weeks.” NCT02551575 ↗ |
| Route | Oral | “Qingre Huoxue granule: 10g, 2 times a day, oral, for 24 weeks.” NCT02551575 ↗ |